MARKET

ZLAB

ZLAB

Zai Lab Limited
NASDAQ
18.44
+0.44
+2.44%
Closed 19:58 02/09 EST
OPEN
17.97
PREV CLOSE
18.00
HIGH
18.80
LOW
17.64
VOLUME
521.14K
TURNOVER
0
52 WEEK HIGH
44.34
52 WEEK LOW
15.96
MARKET CAP
2.04B
P/E (TTM)
-9.4915
1D
5D
1M
3M
1Y
5Y
1D
Bernstein Keeps Their Hold Rating on Zai Lab Ltd (1ZLB)
TipRanks · 20h ago
Weekly Report: what happened at ZLAB last week (0202-0206)?
Weekly Report · 1d ago
Zai Lab Is Maintained at Overweight by JP Morgan
Dow Jones · 4d ago
Zai Lab Price Target Cut to $39.00/Share From $46.00 by JP Morgan
Dow Jones · 4d ago
JP Morgan Maintains Overweight on Zai Lab, Lowers Price Target to $39
Benzinga · 4d ago
NovoCure projects $13M monthly revenue hit as Medicare revokes billing privileges
Seeking Alpha · 4d ago
Zai Lab price target lowered to $39 from $46 at JPMorgan
TipRanks · 4d ago
$207B Market Shift: The Race for Fast Track Approval in Oncology
Barchart · 5d ago
More
About ZLAB
Zai Lab Ltd is a holding company primarily engaged in biopharmaceutical business. The Company is focused on discovering, developing, and commercializing products that address medical conditions with significant unmet needs in the areas of oncology, immunology, neuroscience, and infectious disease. The Company has a series of patented drug candidates from the discovery stage to the late clinical project, including ZEJULA, OPTUNE, QINLOCK, NUZYRA and VYVGART, and others. The Company conducts its businesses within domestic and overseas markets.

Webull offers Zai Lab Ltd - ADR stock information, including NASDAQ: ZLAB real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, ZLAB stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading ZLAB stock methods without spending real money on the virtual paper trading platform.